Company intelligence / Profile preview

AlphaScientia

San Francisco, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

AlphaScientia is a medical communications company serving pharmaceutical, biotech, and medical device/diagnostic clients rather than a therapeutic drug developer. It was launched in 2020 by AlphaGroup Medical Communications to provide premium medical affairs and scientific communications services, including strategic planning, scientific content development, and client services support. The company appears to have operated as part of AlphaGroup alongside AlphaBioCom and AlphaQsci. In December 2022, AlphaGroup was acquired by Red Nucleus, making AlphaScientia part of Red Nucleus Medical Communications. Based on available public information, AlphaScientia is a healthcare-focused services business with no disclosed proprietary clinical pipeline.

Industry: Consulting

Beyond the preview

Go deeper on AlphaScientia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlphaScientia.

Explore the full profile